Haifeng Xu

Overcoming the compensatory elevation of NRF2 renders hepatocellular carcinoma cells more vulnerable to disulfiram/copper-induced ferroptosis

Xueying Ren, Yanchun Li, Yi Zhou et al. · Redox Biology · 2021 · 331 citations · Full text

Medicine, Oncology, Pharmacology +17

Inhibiting the compensatory elevation of xCT collaborates with disulfiram/copper-induced GSH consumption for cascade ferroptosis and cuproptosis

Ping Zhang, Chaoting Zhou, Xueying Ren et al. · Redox Biology · 2023 · 102 citations · Full text

Life Sciences, Biochemistry, Oncology +17

Phase II Study of Hepatic Arterial Infusion Chemotherapy with Oxaliplatin and 5-Fluorouracil for Advanced Perihilar Cholangiocarcinoma

Xiaodong Wang, Jungang Hu, Guang Cao et al. · Radiology · 2016 · 58 citations

Medicine, Oncology, Pharmacotherapy +15

Influence of insulin resistance on in-stent restenosis in patients undergoing coronary drug-eluting stent implantation after long-term angiographic follow-up

Liangping Zhao, Weiting Xu, Li Wang et al. · Coronary Artery Disease · 2014 · 48 citations

Medicine, Cardiology, Endocrinology +17

Risk burdens of modifiable risk factors incorporating lipoprotein (a) and low serum albumin concentrations for first incident acute myocardial infarction

Qin Yang, Yong‐Ming He, Dong-Ping Cai et al. · Scientific Reports · 2016 · 36 citations · Full text

Public Health, Cardiology, Clinical Epidemiology +16